A Case of Low Ejection Fraction Unrelated to Anthracycline Therapy: Chemo Tells a Fib
DOI:
https://doi.org/10.17161/kjm.vol16.19669Keywords:
Cardio toxicity, chemotherapy-induced cardiomyopathy, atrial fibrillation, anthracycline, cardiomyopathy, anthracycline-induced cardiomyopathy, echocardiography, TTE, CMRMetrics
Metrics Loading ...
Downloads
Published
2023-07-25
How to Cite
DeCarr, K. ., Alkhatib, D., Pour-Ghaz, I., Al-Taweel, O. ., Alhwarat, B. ., Bond, A. ., Wineinger, T. ., Alexander, J. ., Kayali, S. ., Yedlapati, N. ., & Rhea, I. . (2023). A Case of Low Ejection Fraction Unrelated to Anthracycline Therapy: Chemo Tells a Fib. Kansas Journal of Medicine, 16(2), 176–178. https://doi.org/10.17161/kjm.vol16.19669
Issue
Section
Case Reports
License
Copyright (c) 2023 Deya Alkhatib, M.D., Kimberly DeCarr, Issa Pour-Ghaz, M.D., Omar Al-Taweel, M.D., Buthainah Alhwarat, M.D., Addison Bond, Tracy Wineinger, MPH, John Alexander, D.O., Sharif Kayali, D.O., Neeraja Yedlapati, M.D., Isaac Rhea, M.D.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0).